<VariationArchive RecordType="classified" VariationID="833362" VariationName="NC_000003.12:g.(?_15601831)_(15601914_?)del" VariationType="Deletion" Accession="VCV000833362" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-03-26" DateCreated="2020-04-15" MostRecentSubmission="2020-04-15">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="819342" VariationID="833362">
      <GeneList>
        <Gene Symbol="BTD" FullName="biotinidase" GeneID="686" HGNC_ID="HGNC:1122" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>3p25.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="15601361" stop="15722516" display_start="15601361" display_stop="15722516" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="15643254" stop="15687324" display_start="15643254" display_stop="15687324" Strand="+" />
          </Location>
          <OMIM>609019</OMIM>
          <Property>gene_acmg_incidental_2021</Property>
          <Property>gene_acmg_incidental_2022</Property>
        </Gene>
      </GeneList>
      <Name>NC_000003.12:g.(?_15601831)_(15601914_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>3p25.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" innerStart="15643338" innerStop="15643421" display_start="15643338" display_stop="15643421" variantLength="84" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.11" sequenceAccession="NC_000003" sequenceVersion="11" change="g.(?_15643338)_(15643421_?)del" Assembly="GRCh37">
            <Expression>NC_000003.11:g.(?_15643338)_(15643421_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000003.12:g.(?_15601831)_(15601914_?)del AND Biotinidase deficiency" Accession="RCV001033806" Version="1">
        <ClassifiedConditionList TraitSetID="482">
          <ClassifiedCondition DB="MedGen" ID="C0220754">Biotinidase deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-10-07" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2019-10-07" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2020-04-15" MostRecentSubmission="2020-04-15">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="482" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1025" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Biotinidase deficiency</ElementValue>
                <XRef ID="Biotinidase+Deficiency/846" DB="Genetic Alliance" />
                <XRef ID="MONDO:0009665" DB="MONDO" />
                <XRef ID="8808004" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Biotin deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">BTD deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Late-onset biotin-responsive multiple carboxylase deficiency</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">If untreated, young children with profound biotinidase deficiency usually exhibit neurologic abnormalities including seizures, hypotonia, ataxia, developmental delay, vision problems, hearing loss, and cutaneous abnormalities (e.g., alopecia, skin rash, candidiasis). Older children and adolescents with profound biotinidase deficiency often exhibit motor limb weakness, spastic paresis, and decreased visual acuity. Once vision problems, hearing loss, and developmental delay occur, they are usually irreversible, even with biotin therapy. Individuals with partial biotinidase deficiency may have hypotonia, skin rash, and hair loss, particularly during times of stress.</Attribute>
                <XRef ID="NBK1322" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="894" />
                <XRef ID="894" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301497</ID>
                <ID Source="BookShelf">NBK1322</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT Sheet, 2010">
                <URL>https://www.ncbi.nlm.nih.gov/books/NBK55827/bin/Biotinidase.pdf</URL>
                <CitationText>American College of Medical Genetics ACT SHEET, Biotinidase Deficiency</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2006">
                <URL>https://www.ncbi.nlm.nih.gov/books/NBK55827/bin/Visio-Biotinidase.pdf</URL>
                <CitationText>American College of Medical Genetics Algorithm, Biotinidase Deficiency, 2006</CitationText>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGentest, 2012">
                <ID Source="PubMed">22378278</ID>
              </Citation>
              <Citation Type="general" Abbrev="CDC, 2012">
                <ID Source="PubMed">22475884</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2017">
                <ID Source="PubMed">28682309</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Biotinidase-Deficiency-ACT-Sheet.pdf</URL>
                <CitationText>American College of Medical Genetics ACT Sheet, Newborn Screening ACT Sheet, [Absent/ Reduced Biotinidase Activity], Biotinidase Deficiency</CitationText>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>http://www.acmg.net/ACMG/UploadedPDFS/PDFDocuments/Biotinidase-Deficiency.aspx</URL>
                <CitationText>American College of Medical Genetics Algorithm, Biotinidase Deficiency, 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Biotinidase-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, Biotinidase Deficiency, 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2022">
                <URL>https://www.acmg.net/PDFLibrary/C5-OH.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Elevated C5-OH Acylcarnitine, Organic Acidemias, 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>https://www.acmg.net/PDFLibrary/C5-OH-Elevated.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, Organic Acidemias: Elevated C5-OH, 2022</CitationText>
              </Citation>
              <XRef ID="79241" DB="Orphanet" />
              <XRef ID="C0220754" DB="MedGen" />
              <XRef ID="MONDO:0009665" DB="MONDO" />
              <XRef Type="MIM" ID="253260" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2358369" SubmissionDate="2020-02-06" DateLastUpdated="2020-04-15" DateCreated="2020-04-15">
        <ClinVarSubmissionID localKey="3071464|MedGen:C0220754" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001197113" DateUpdated="2020-04-15" DateCreated="2020-04-15" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-10-07">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>This variant is a gross deletion of the genomic region encompassing exon 1 of the BTD gene, which includes the initiator codon. The 5' end of this event is unknown as it extends beyond the assayed region for this gene and therefore may encompass additional genes. The 3' boundary is likely confined to intron 1 of the BTD gene. This is expected to result in an absent or disrupted protein product. This variant has not been reported in the literature in individuals with BTD-related conditions. Loss-of-function variants in BTD are known to be pathogenic (PMID: 20083419). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="BTD" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000003.11:g.(?_15643338)_(15643421_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Biotinidase deficiency</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C0220754" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6933794</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2358369" TraitType="Disease" MappingType="Name" MappingValue="Biotinidase deficiency" MappingRef="Preferred">
        <MedGen CUI="C0220754" Name="Biotinidase deficiency" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

